Umicore S.A. (UMI)
Euronext Brussels · Belgium · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 18.61 |
|---|---|
| 52-week range | 14.19 – 26.98 |
| Return, 1 month / 3 months | −13.0% / −7.2% |
| Return, 1 year / 3 years | +12.8% / −7.5% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 46.9% |
| Worst drawdown (1 year) | -35.0% |
| Average daily value traded | 9.06M EUR |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Umicore is a materials technology and recycling company based in Belgium. It makes catalysts for cleaning vehicle exhaust, precious metal products and specialty materials, and it recovers and refines metals from industrial residues and end-of-life products such as used batteries. Its customers are manufacturers in the automotive, electronics, chemical and energy industries, who rely on its materials and recycling services to obtain metals and reduce their environmental impact.
On this site Umicore S.A. appears as a stock on the Euronext Brussels (Belgium), code UMI, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Umicore S.A. (UMI) trades on the Euronext Brussels in Belgium. It last closed at EUR 18.61 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 56 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.8% and over the last three months it fell 7.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.7% | ||
| From 52-week high | -29.8% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.2% | ||
| 6-month return | 11.9% | ||
| 12-month return, skipping the last month | 29.7% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 46.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.0% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 9.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | −13.0% |
| 3 months | −7.2% |
| 6 months | +11.9% |
| 1 year | +12.8% |
| 3 years | −7.5% |
| 5 years | −55.8% |
Signals
| 50-day / 200-day average | 21.45 / 20.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | EUR 0.5000 |
| 28 Apr 2025 | EUR 0.2500 |
| 19 Aug 2024 | EUR 0.2500 |
| 29 Apr 2024 | EUR 0.5500 |
| 18 Aug 2023 | EUR 0.2500 |
| 2 May 2023 | EUR 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.